Profile of adipose tissue gene expression in premenopausal and postmenopausal women: Site-specific differences

Menopause

Volumn 18, Issue 6, 2011, Pages 675-684

  Gomez Santos, Cecilia ^a   Hernandez Morante, Juan J ^a,b   Margareto, Javier ^c   Larrarte, Eider ^c   Formiguera, Xavier ^d   Martínez, Carlos Manuel ^e   Garaulet, Marta ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b CATHOLIC UNIVERSITY OF MURCIA   (Spain)

^c TECNALIA RESEARCH AND INNOVATION   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Adipose tissue; Keratyn 7; Menopause; Metallothionein 1E; Microarray; Neurexin 3

Indexed keywords

CYTOKERATIN 7; METALLOTHIONEIN 1E; METALLOTHIONEIN I; NEUREXIN; NEUREXIN 3; RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; IMMUNE SYSTEM; INTRAABDOMINAL FAT; MORBID OBESITY; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PREMENOPAUSE; RECEPTOR DOWN REGULATION; RNA EXTRACTION; SUBCUTANEOUS FAT; UNINDEXED SEQUENCE;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MENOPAUSE; MIDDLE AGED; OBESITY, MORBID; PREMENOPAUSE; RNA, MESSENGER; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION;

EID: 79958785418     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31820641da     Document Type: Article

References (28)

1. Teede HJ, Lombard C, Deeks AA. Obesity, metabolic complications and the menopause: an opportunity for prevention. Climacteric 2009;13: 203-209.
2. Hale GE, Burger HG. Hormonal changes and biomarkers in late reproductive age, menopausal transition and menopause. Best Pract Res Clin Obstet Gynaecol 2009;23:7-23.
3. Dvornyk V, Liu Y, Lu Y, et al. Effect of menopause on gene expression profiles of circulating monocytes: a pilot in vivo microarray study. J Genet Genomics 2007;34:974-983. (Pubitemid 350123213)
4. Tchernof A, Poehlman ET, Després JP. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 2000;26:12-20. (Pubitemid 30146088)
5. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411. (Pubitemid 36724404)
6. Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause-related changes in body fat distribution. Ann N Y Acad Sci 2000;904:502-506. (Pubitemid 30389242)
7. Garaulet M, Hernández-Morante JJ, Tébar FJ, Zamora S. Anthropometric indexes for visceral fat estimation in overweight/obese women attending to age and menopausal status. J Physiol Biochem 2006;62:245-252. (Pubitemid 46938953)
8. Zimmet P, George K, Alberti MM, Serrano M. Una nueva definición mundial del síndrome metabólico propuesta por la Federación Inter-nacional de Diabetes: fundamento y resultados [article in Spanish]. Rev Esp Cardiol 2005;58:1371-1376. (Pubitemid 43193350)
9. Garaulet M, Hernandez-Morante JJ, Lujan J, Tebar FJ, Zamora S. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int J Obes (Lond) 2006;30:899-905. (Pubitemid 43801188)
10. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-355. (Pubitemid 40277057)
11. Hernandez-Morante JJ, Milagro F, Gabaldon JA, Martinez JA, Zamora S, Garaulet M. Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol 2006;155:593-600. (Pubitemid 44608433)
12. Ritchie JD, Miller CK, Smiciklas-Wright H. Tanita foot-to-foot bio-electrical impedance analysis system validated in older adults. J Am Diet Assoc 2005;105:1617-1619. (Pubitemid 41393046)
13. The Gene Ontology Consortium. The gene ontology project in 2008. Nucleic Acid Res 2008;36:D440-D444.
14. j$$Ct method. Methods 2001; 25:402-408. (Pubitemid 34164012)
15. Marrades MP, Milagro FI, Mart́inez JA, Moreno-Aliaga MJ. Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Biochem Biophys Res Commun 2006;339:785-789. (Pubitemid 41772882)
16. Alberti KG, Zimmet P, Shaw J. Metabolic syndromeVa new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
17. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738. (Pubitemid 32113289)
18. Garaulet M, Pérez-Llamas F, Baraza JC, et al. Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. J Nutr Health Aging 2002;6:123-126. (Pubitemid 34415238)
19. Lachman HM, Fann CS, Bartzis M, et al. Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum Mol Genet 2007;16: 1327-1334. (Pubitemid 47055128)
20. Heard-Costa NL, Zillikens MC, Monda KL, et al. NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet 2009;5:e1000539.
21. Yeung DC, Lam KS, Wang Y, Tso AW, Xu A. Serum zinc->2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab 2009;94:2531-2536.
22. Albertus DL, Seder CW, Chen G, et al. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. J Thorac Oncol 2008;3:1236-1244.
23. Kim JS, Huang TY, Bokoch GM. Reactive oxygen species regulate a slingshot-cofilin activation pathway. Mol Biol Cell 2009;20:2650-2660.
24. Wan H, South AP, Hart IR. Increased keratinocyte proliferation initiated through downregulation of desmoplakin by RNA interference. Exp Cell Res 2007;313:2336-2344. (Pubitemid 46900938)
25. Coyle P, Philcox JC, Carey LC, et al. Metallothionein: the multipurpose protein. Cell Mol Life Sci 2002;9:627-647. (Pubitemid 34460681)
26. Kagi JH. Overview of metallothionein. Methods Enzymol 1991;205: 613-626.
27. Lundquist K, Kohler S, Rouse RV. Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells. Am J Surg Pathol 1999;23:212-219. (Pubitemid 29075163)
28. Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002;38:758-763. (Pubitemid 34280319)